AIM ImmunoTech (AIM) Return on Sales (2010 - 2026)
AIM ImmunoTech's (AIM) quarterly Return on Sales came in at 1.47% in Q1 2026, up 92.0% YoY from 0.76% in Q1 2025, and up 4.84% on a QoQ basis from 1.54% in Q4 2025.
AIM ImmunoTech (AIM) Return on Sales (2010 - 2026) Analysis & Trends
AIM ImmunoTech (AIM) has 17 years of Return on Sales data on file, last reported at 1.47% in Q1 2026.
- Quarterly Return on Sales rose 92.0% year-over-year to 1.47% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.49% (down 6.0% YoY) and the FY2025 annual result came in at 6.65%, down 296.0% from the prior year.
- Return on Sales grew to 1.47% in Q1 2026, from 1.54% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.92% in Q1 2023 to a low of 3.22% in Q3 2022.
- A 5-year average of 1.62% and a median of 1.47% in 2026 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2022 — Return on Sales tumbled 168 bps — and 2023, when it jumped 140 bps.
- Tracing AIM's Return on Sales over 5 years: stood at 1.01% in 2022, then plunged by 116 bps to 2.18% in 2023, then surged by 39 bps to 1.33% in 2024, then retreated by 16 bps to 1.54% in 2025, then rose by 5 bps to 1.47% in 2026.
- The last three Return on Sales figures came in at 1.47% (Q1 2026), 1.54% (Q4 2025), and 1.01% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.33 Bn | 78.34 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.13 Bn | 59.95 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 60.47 Bn | 55.33 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.04 Bn | 27.73 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.48 Bn | 10.09 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.23 Bn | 26.39 Bn | - | 0.00% |
| 10 | AIM ImmunoTech | 4.37 Mn | -5.60 Mn | 21,000.00 | -1.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.74% |
| Mar 31, 2026 | -1.47% |
| Dec 31, 2025 | -1.54% |
| Sep 30, 2025 | -1.01% |
| Jun 30, 2025 | -1.97% |
| Mar 31, 2025 | -2.38% |
| Dec 31, 2024 | -1.33% |
| Sep 30, 2024 | -1.35% |
| Jun 30, 2024 | -1.27% |
| Mar 31, 2024 | -2.08% |
| Dec 31, 2023 | -2.18% |
| Sep 30, 2023 | -1.82% |
| Jun 30, 2023 | -1.35% |
| Mar 31, 2023 | -0.92% |
| Dec 31, 2022 | -1.01% |
| Sep 30, 2022 | -3.22% |
| Jun 30, 2022 | -1.62% |
| Mar 31, 2022 | -1.01% |
| Dec 31, 2021 | -1.49% |
| Sep 30, 2021 | -1.54% |